Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model
Article
Published on
Journal: Journal of Antimicrobial Chemotherapy [Category] COVID19(2023년), SARS, 진단, 치료제,
Journal: Journal of Antimicrobial Chemotherapy [Category] COVID19(2023년), SARS, 진단, 치료제,
[키워드] acute respiratory syndrome
Administered
age
anti-SARS-CoV-2
Antiviral
Antiviral compound
antiviral efficacy
body weight
Body weight loss
caused
Cell
clinical development
coronavirus
coronavirus disease
correlated
COVID-19
demonstrated
development
dose
dose-dependent manner
effective
Efficacy
evaluated
expression
general treatment
Health
in vivo
increased survival
Inflammatory
Intervention
lung
Lung inflammation
Lung pathology
mice
mouse-adapted SARS-CoV-2
nucleocapsid protein
pandemic
patients with COVID-19
Post-infection
protease
pulmonary lesion
quantified
reduced
reduced viral load
RNA
RT-qPCR
Safe
SARS-CoV-2
SARS-COV-2 infection
Support
suppressed
survival
target
the SARS-CoV-2
titre
treat
Treatment
Viral RNA
was used
were infected
[DOI] 10.1093/jac/dkac257 PMC 바로가기
[DOI] 10.1093/jac/dkac257 PMC 바로가기